Similarly, we did not find any difference between the two animal groups in either the numbers of proliferating Ki67+ cells within the grafts (Fig. 1c and f-g) or the percentage of grafted cells immunopositive for the neuroblast marker DCX (59 ± 2.6% and 54.5 ± 4.3% of grafted cells in intact and stroke-injured rats, respectively; Fig. 1h-i). This evidence concerns the gene MKI67 and stroke disorder.